We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Site-Selective Labeling of a Lysine Residue in Human Serum Albumin.
- Authors
Asano, Shigehiro; Patterson, James T.; Gaj, Thomas; Barbas, Carlos F.
- Abstract
Conjugation to human serum albumin (HSA) has emerged as a powerful approach for extending the in vivo half-life of many small molecule and peptide/protein drugs. Current HSA conjugation strategies, however, can often yield heterogeneous mixtures with inadequate pharmacokinetics, low efficacies, and variable safety profiles. Here, we designed and synthesized analogues of TAK-242, a small molecule inhibitor of Toll-like receptor 4, that primarily reacted with a single lysine residue of HSA. These TAK-242-based cyclohexene compounds demonstrated robust reactivity, and Lys64 was identified as the primary conjugation site. A bivalent HSA conjugate was also prepared in a site-specific manner. Additionally, HSA-cyclohexene conjugates maintained higher levels of stability both in human plasma and in mice than the corresponding maleimide conjugates. This new conjugation strategy promises to broadly enhance the performance of HSA conjugates for numerous applications.
- Subjects
LYSINE; SERUM albumin; PEPTIDE drugs; PHARMACOKINETICS; SMALL molecules; TOLL-like receptors
- Publication
Angewandte Chemie International Edition, 2014, Vol 53, Issue 44, p11783
- ISSN
1433-7851
- Publication type
Article
- DOI
10.1002/anie.201405924